Literature DB >> 23510566

Predictors of the disappearance of triad symptoms in patients with idiopathic normal pressure hydrocephalus after shunt surgery.

Hiroaki Kazui1, Etsuro Mori, Shingo Ohkawa, Takaharu Okada, Takeo Kondo, Ryuji Sakakibara, Osamu Ueki, Yoshiyuki Nishio, Kazunari Ishii, Tetsuro Kawaguchi, Masatsune Ishikawa, Masatoshi Takeda.   

Abstract

We identified factors that predict the disappearance of the triad of symptoms (gait disturbance, cognitive impairment and urinary incontinence) of idiopathic normal pressure hydrocephalus (iNPH) following shunt surgery in this study. We classified 71 patients with iNPH into those whose objective symptoms disappeared (disappearance group) or remained (residual group), for each of the triad symptoms 12 months after shunt surgery. Logistic regression analyses were used to identify the predictors of the disappearance of symptoms among 10 variables before shunt surgery (e.g., age, sex, severity of symptoms, Evans index, cerebrospinal fluid (CSF) pressure, CSF stasis on computerized tomographic cisternography, regional cerebral blood flow on single photon emission computed tomography, three kinds of prior diseases). For each of the triad symptoms, mild symptoms before shunt surgery were predictors of the disappearance of the symptom. Young age was also a predictor of the disappearance of gait disturbance. When the analysis was conducted using subscores of the Mini Mental State Examination, a successful visuoconstruction subtest and an absence of hypertension were predictors of the disappearance of cognitive impairment. None of the neuroimaging examinations predicted the disappearance of symptoms after shunt surgery in this study.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23510566     DOI: 10.1016/j.jns.2013.02.020

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Absence of Disproportionately Enlarged Subarachnoid Space Hydrocephalus, a Sharp Callosal Angle, or Other Morphologic MRI Markers Should Not Be Used to Exclude Patients with Idiopathic Normal Pressure Hydrocephalus from Shunt Surgery.

Authors:  S Agerskov; M Wallin; P Hellström; D Ziegelitz; C Wikkelsö; M Tullberg
Journal:  AJNR Am J Neuroradiol       Date:  2018-12-06       Impact factor: 3.825

2.  Evaluation of Patients With Cognitive Impairment Due to Suspected Idiopathic Normal-Pressure Hydrocephalus at Medical Centers for Dementia: A Nationwide Hospital-Based Survey in Japan.

Authors:  Hiroaki Kazui; Mamoru Hashimoto; Shigetoshi Takeda; Yasuji Chiba; Tokiko Goto; Katsuhiro Fuchino
Journal:  Front Neurol       Date:  2022-05-27       Impact factor: 4.086

3.  Serial Tap Test of patients with idiopathic normal pressure hydrocephalus: impact on cognitive function and its meaning.

Authors:  Samanta Fabrício Blattes da Rocha; Pedro André Kowacs; Ricardo Krause Martinez de Souza; Matheus Kahakura Franco Pedro; Ricardo Ramina; Hélio A Ghizoni Teive
Journal:  Fluids Barriers CNS       Date:  2021-05-06

4.  Hypertension and Risk of Post-Operative Cognitive Dysfunction (POCD): A Systematic Review and Meta-Analysis.

Authors:  I Feinkohl; G Winterer; T Pischon
Journal:  Clin Pract Epidemiol Ment Health       Date:  2017-05-18

5.  The role of shuntography in diagnosis of mechanic complications after implantation of ventriculoperitoneal shunts in patients with idiopathic normal pressure hydrocephalus: a retrospective clinical evaluation.

Authors:  Sergej Rot; Leonie Goelz; Holger Arndt; Pawel Gutowski; Ullrich Meier; Johannes Lemcke
Journal:  Neuroradiology       Date:  2021-11-26       Impact factor: 2.804

Review 6.  Clinical predictors of shunt response in the diagnosis and treatment of idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis.

Authors:  Santhosh G Thavarajasingam; Mahmoud El-Khatib; Mark Rea; Salvatore Russo; Johannes Lemcke; Lana Al-Nusair; Peter Vajkoczy
Journal:  Acta Neurochir (Wien)       Date:  2021-07-08       Impact factor: 2.216

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.